116 related articles for article (PubMed ID: 12834817)
61. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
[TBL] [Abstract][Full Text] [Related]
62. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
63. Facilitation of 9,10-phenanthrenequinone-elicited neuroblastoma cell apoptosis by NAD(P)H:quinone oxidoreductase 1.
Matsunaga T; Kamase K; Takasawa H; Yamaji Y; Endo S; El-Kabbani O; Ikari A
Chem Biol Interact; 2018 Jan; 279():10-20. PubMed ID: 29108775
[TBL] [Abstract][Full Text] [Related]
64. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations.
Gaedigk A; Tyndale RF; Jurima-Romet M; Sellers EM; Grant DM; Leeder JS
Pharmacogenetics; 1998 Aug; 8(4):305-13. PubMed ID: 9731717
[TBL] [Abstract][Full Text] [Related]
65. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
[TBL] [Abstract][Full Text] [Related]
66. Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites.
Covarrubias VG; Lakhman SS; Forrest A; Relling MV; Blanco JG
Toxicol Lett; 2006 Jul; 164(3):249-58. PubMed ID: 16478651
[TBL] [Abstract][Full Text] [Related]
67. Role of NQO1 609C>T and NQO2-3423G>A polymorphisms in susceptibility to gastric cancer in Kashmir valley.
Malik MA; Zargar SA; Mittal B
DNA Cell Biol; 2011 May; 30(5):297-303. PubMed ID: 21294640
[TBL] [Abstract][Full Text] [Related]
68. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
[TBL] [Abstract][Full Text] [Related]
69. The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer.
Gorący J; Bogacz A; Uzar I; Wolek M; Łochyńska M; Ziętek P; Czerny B; Cymbaluk-Płoska A; Modliborski P; Kamiński A
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356648
[TBL] [Abstract][Full Text] [Related]
70. NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis.
Agúndez JA; García-Martín E; Martínez C; Benito-León J; Millán-Pascual J; Calleja P; Díaz-Sánchez M; Pisa D; Turpín-Fenoll L; Alonso-Navarro H; Ayuso-Peralta L; Torrecillas D; Plaza-Nieto JF; Jiménez-Jiménez FJ
BMC Neurol; 2014 Apr; 14():87. PubMed ID: 24755231
[TBL] [Abstract][Full Text] [Related]
71. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family.
Vasiliou V; Ross D; Nebert DW
Hum Genomics; 2006 Mar; 2(5):329-35. PubMed ID: 16595077
[TBL] [Abstract][Full Text] [Related]
72. A possible association between an insertion/deletion polymorphism of the NQO2 gene and schizophrenia.
Harada S; Tachikawa H; Kawanishi Y
Psychiatr Genet; 2003 Dec; 13(4):205-9. PubMed ID: 14639047
[TBL] [Abstract][Full Text] [Related]
73. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients.
Tsvetkov P; Adamovich Y; Elliott E; Shaul Y
J Biol Chem; 2011 Mar; 286(11):8839-45. PubMed ID: 21220432
[TBL] [Abstract][Full Text] [Related]
74. The Role of NQO1 in Ovarian Cancer.
Tossetta G; Fantone S; Goteri G; Giannubilo SR; Ciavattini A; Marzioni D
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175546
[TBL] [Abstract][Full Text] [Related]
75. Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
Newsome JJ; Hassani M; Swann E; Bibby JM; Beall HD; Moody CJ
Bioorg Med Chem; 2013 Jun; 21(11):2999-3009. PubMed ID: 23635904
[TBL] [Abstract][Full Text] [Related]
76. Association of human NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism with development of acute lung injury.
Reddy AJ; Christie JD; Aplenc R; Fuchs B; Lanken PN; Kleeberger SR
J Cell Mol Med; 2009 Aug; 13(8B):1784-1791. PubMed ID: 19017358
[TBL] [Abstract][Full Text] [Related]
77. Kinetics of Flavoenzyme-Catalyzed Reduction of Tirapazamine Derivatives: Implications for Their Prooxidant Cytotoxicity.
Nemeikaitė-Čėnienė A; Šarlauskas J; Jonušienė V; Marozienė A; Misevičienė L; Yantsevich AV; Čėnas N
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533349
[TBL] [Abstract][Full Text] [Related]
78. Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies.
Schulz WA; Krummeck A; Rösinger I; Eickelmann P; Neuhaus C; Ebert T; Schmitz-Dräger BJ; Sies H
Pharmacogenetics; 1997 Jun; 7(3):235-9. PubMed ID: 9241663
[TBL] [Abstract][Full Text] [Related]
79. Quinone reductase 2 is a catechol quinone reductase.
Fu Y; Buryanovskyy L; Zhang Z
J Biol Chem; 2008 Aug; 283(35):23829-35. PubMed ID: 18579530
[TBL] [Abstract][Full Text] [Related]
80. A bioluminescent probe for NQO1 overexpressing cancer cell imaging
Luo Y; Wang W; Zeng Y; Wang S; Guo X; Hu R; Yang G
Analyst; 2022 Nov; 147(23):5264-5268. PubMed ID: 36330961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
